The slip
PARKINSON RECEIPTno. 0414
17 Oct 2026, 00:11 UTCdopamine neurons, braak
predictionRAB29 in dopamine neurons tracks Braak Lewy-body stage
registeredcab13366006c34f1
discovery-0.50 p=0.168 n=9
replication+0.21 p=0.583 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.50, p 0.168)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT10b6bc874e7d4b2d0acfc38c…
follows 869efd33e65a…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 0414: RAB29 in dopamine neurons, braak
- power
- full sample -0.30 (p 0.232, n 18), 95% CI -0.67 to +0.20. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.30 (p 0.232, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.30 (p 0.232, n 18). could be the mix.
- skeptic
- leave-one-out range -0.40 to -0.19, sign flips 0; without severely affected donors -0.30 (p 0.232, n 18). fragile.
- cell type
- strongest in OPCs: -0.62 (p 0.0062, n 18) vs -0.30 in dopamine neurons. proposing OPCs.
- axis
- no measure beats "tracks Braak Lewy-body stage" for RAB29 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up RAB29 · OPCs · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.28 p 0.328 (needs p < 0.0018)